Start-Up Stadium is designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital at the world’s largest biotechnology partnering event.
During the 2024 BIO International Convention, 47 select finalists from 13 different countries each shared a quick pitch showcasing new technologies and therapeutic solutions to a panel of investor judges, followed by live feedback. Finalists were eligible for a highly discounted registration rate to attend the 2024 BIO International Convention.
Evaluation of the presentations from seed-stage company finalists (less than $1M raised) occurred separately from emerging company finalists (more than $1M but less than $10M raised to date), with a winner identified for each category.
Winners are listed after the finalists below and applications for 2025 will open by November 2024.